Atlas Trials

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

Clinical trial NCT05251038 · WITHDRAWN

Trial details

NCT number
NCT05251038
Sponsor
Devalingam Mahalingam
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic CancerKRAS P.G12C
Start date
2022-09-13
Primary completion
2023-01-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.